Analyst Ratings for Sutro Biopharma (STRO)
STRO Rating Summary
STRO Price Target Summary
- Highest: $18.00 (Truist Securities)
- Lowest: $8.00 (Wedbush)
- Average: $11.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.83 (+211.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$11.83 (+211.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2023 | Deutsche Bank | James Shin | New Coverage | Buy (N/A) |
12.00 (N/A) |
2.62 (3.80) |
45.04% | Details |
| 10/5/2023 | Oppenheimer » Updated 4/3/2024 |
Jay Olson | New Coverage | Outperform (N/A) |
10.00 (N/A) |
3.16 (3.80) |
20.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
